ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
The 6 meanings of “Lack of Access” (UNSLAP)
Assessing antibiotic value: DTR, fire extinguishers, and a view from Australia
FDA AMDAC – Developing Single-Pathogen agents for P. aeruginosa and A. baumannii
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
Mirror Bacteria: An AMR threat of unprecedented magnitude
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Anti-Gram-negative beta-lactams in jeopardy: The rise of PBP3 mutations
DTR Gram-negative infections: Are new antibiotics making a difference?
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet










